BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2017
View Archived Issues
Selecta initiates phase I trial of nicotine vaccine candidate SELA-070
Read More
Ono Pharmaceutical updates key developments of fourth quarter of fiscal 2016
Read More
Seikagaku and Ono enter codevelopment and marketing collaboration on SI-613
Read More
ALLSTAR phase II trial of CAP-1002 unlikely to achieve primary efficacy endpoint
Read More
SB-415286 provides small molecule inhibition of PD-1 transcription
Read More
AAV9-CMV-TIPE2, a novel gene therapy for Duchenne muscular dystrophy
Read More
Ardelyx's phase III T3MPO-1 study of tenapanor meets primary endpoint
Read More
FDA grants fast track designation to Biohaven's trigriluzole for spinocerebellar ataxia
Read More
Esteve presents sigma 1 receptor ligands
Read More
French ANSM requests temporary suspension of masitinib trials in France
Read More
Hua Medicine patents metabotropic glutamate mGlu5 receptor antagonists
Read More
Trillium Therapeutics identifies novel fluorinated heterocycle derivatives
Read More
Boehringer Ingelheim discovers plasma kallikrein inhibitors
Read More
Pacira studies DepoTXA to reduce bleeding after total knee arthroplasty
Read More
Larotrectinib receives U.S. orphan designation for solid tumors with NTRK-fusion proteins
Read More
Daiichi Sankyo presents key milestones of fourth quarter of fiscal 2016
Read More
Shionogi & Co. divulges MGAT2 inhibitors
Read More
Polyclonal antibody preparation BT-086 can reduce severe community-acquired pneumonia mortality
Read More
Alunbrig available to order in U.S.
Read More
AbbVie reports pooled phase III outcomes data on ibrutinib in CLL/SLL
Read More
Galenica Ltd. shareholders approve change of name to Vifor Pharma Ltd.
Read More
Eli Lilly presents positive data from phase III studies of galcanezumab
Read More
SymBio suspends enrollment in phase III trial of SyB P-1501
Read More
pCCLChim-p47 gene therapy for autosomal-recessive chronic granulomatous disease shows promise
Read More
Phase Ib study shows potential of NGM-282 to treat constipation
Read More
Sumitomo Dainippon Pharma reviews developments of fourth quarter of fiscal 2016
Read More
Novartis' KAF-156 granted FDA orphan drug designation for malaria
Read More